Safir Melaine
Sanofi Genzyme Oncology & Hematology leader — China & Emerging Markets
Paris, France
Summary
Oncology and hematology franchise leadership focused on China and emerging markets — drives commercialization and access strategies for innovative cancer medicines across the region. linkedin
Partnership and ecosystem builder — frequently leads strategic collaborations with Chinese institutions and regional initiatives (examples: partnerships with Lecheng/Suzhou research centres, PSCC, and Hainan real‑world data institute) to accelerate clinical evaluation and early patient access. pharmcube+2
Active communicator and thought leader — publishes first‑person LinkedIn pieces describing on‑the‑ground collaborations, cross‑functional team visits and the practical steps Sanofi is taking to serve cancer patients in China and globally. linkedin+1
Clinically trained background — holds a Doctorat en Médecine, informing a focus on clinical translation, real‑world evidence and faster access pathways for patients. frenchhealthcare
Work
Education
Writing
Team work in action!
October 1, 2023LinkedIn article describing Sanofi Global Oncology's focus on China, visits with cross‑functional teams and partnerships in China, and reinforcement of collaboration to accelerate research and access for cancer patients.
Strategic cooperation with the Hainan Institute of Real World Data
May 1, 2023LinkedIn article summarising the signing of a strategic cooperation agreement with the Hainan Institute of Real World Data to advance early access to innovative drugs in oncology and rare diseases through pilot trials, real‑world data and academic exchanges.